What is the recommended treatment regimen for severe malaria using Alpha beta Arteether (Arteether) injection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Alpha Beta Arteether Treatment Regimen for Severe Malaria

For severe malaria, the recommended treatment regimen with Alpha beta Arteether (Arteether) injection is 150 mg intramuscularly once daily for 3 consecutive days.

Treatment Protocol for Severe Malaria with Arteether

Initial Assessment and Management

  • Severe malaria is a medical emergency requiring prompt treatment
  • Identify signs of severe malaria:
    • Cerebral malaria (drowsiness, mental confusion, coma, seizures)
    • Severe anemia
    • Hemoglobinuria, oliguria, or anuria
    • Hypotension and respiratory distress
    • Jaundice
    • Hemorrhagic diatheses

Arteether Dosing Regimen

  • Administer 150 mg intramuscularly once daily for 3 consecutive days 1, 2, 3, 4
  • Intramuscular administration is preferred in patients who cannot take oral medications or have persistent vomiting

Expected Response to Treatment

  • Median parasite clearance time: 2 days (range 1-4 days) 1, 3
  • Median fever clearance time: 52-72 hours 1, 3
  • Recovery from coma in cerebral malaria: median 18 hours (range 6-72 hours) 1

Supportive Care During Treatment

  • Monitor for hypoglycemia, which is a complicating factor in cerebral malaria 5
  • Maintain adequate hydration while avoiding fluid overload 5
  • Consider blood transfusion if hemoglobin is <4 g/dL or <6 g/dL with signs of heart failure 5
  • Manage seizures promptly with appropriate anticonvulsants 5

Important Considerations

Efficacy and Safety

  • Arteether shows rapid parasite clearance and recovery from complications 1, 3
  • No significant side effects or drug toxicity have been reported 1, 2, 3
  • Cure rates of 93-100% have been observed in clinical studies 2, 4

Alternative Treatments

  • WHO and more recent guidelines recommend intravenous artesunate as first-line treatment for severe malaria 5
  • If artesunate is unavailable, arteether is an effective alternative
  • In settings where neither is available, intravenous quinine can be used 5

Potential Pitfalls

  1. Recrudescence risk: Recrudescence rates of 6.7-14% have been observed 1, 2, 3

    • Follow patients for at least 28 days after treatment
    • Consider follow-up with a complete oral antimalarial regimen
  2. Delayed response: Unlike artesunate, arteether may show slower clinical response 6

    • Do not prematurely switch treatments if immediate response isn't observed
    • Continue monitoring parasitemia and clinical status
  3. Drug accumulation: Arteether can accumulate in blood with repeated dosing 6

    • Adhere to the recommended 3-day regimen
    • Avoid extending treatment beyond recommended duration
  4. Monitoring requirements: Regular monitoring of parasitemia, consciousness level, and vital signs is essential during treatment 5

    • Check blood glucose levels frequently, especially in patients with altered consciousness
    • Monitor renal function and fluid balance

By following this treatment regimen with appropriate supportive care, Alpha beta Arteether injection can effectively treat severe malaria with good clinical outcomes and minimal side effects.

References

Research

alpha, beta-Arteether for the treatment of complicated falciparum malaria.

Transactions of the Royal Society of Tropical Medicine and Hygiene, 1997

Research

Effectiveness of alpha,beta-arteether in acute falciparum malaria.

Transactions of the Royal Society of Tropical Medicine and Hygiene, 1995

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.